Literature DB >> 9844990

Role of free oxygen radicals and prostanoids in the pathogenesis of Henoch-Schönlein Purpura.

N Buyan1, D Erbaş, N Akkök, E Oz, G Biberoğlu, E Hasanoğlu.   

Abstract

The pathogenesis of Henoch-Schonlein Purpura (HSP) is still controversial. The aim of our study was to investigate the role of oxidative stress and cyclooxygenase (CO) pathway products in the pathogenesis of HSP. In order to investigate this, malondialdehyde (MDA) levels, indicating lipid peroxidation, prostaglandin E (PGE)-like activity as inflammatory mediator and vitamin E (vit-E) levels indicating anti-oxidant status were studied in a group of 10 children with HSP (five girls and five boys, aged 6-21 years, mean 10.7 years), both in the acute and recovery phase of the disease and in five age and sex-matched healthy children as a control group. The patients were also grouped into low and high clinical score groups. Plasma levels of MDA and PGE-like activity were significantly elevated in the active phase of HSP compared to the recovery phase. Vit-E levels were significantly reduced in the active phase compared to the recovery phase. The plasma levels of PGE-like activity of the patients obtained in the active phase were significantly higher than the levels of the control group, whereas the levels of the recovery phase were significantly lower than in the control group. No such difference between the controls and MDA and vit-E levels in the patient group was shown. No correlation between the clinical scores and the parameters studied could be found. Our findings indicate that oxidant stress and CO pathway products may play a role in the pathogenesis of HSP.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9844990     DOI: 10.1016/s0952-3278(98)90060-6

Source DB:  PubMed          Journal:  Prostaglandins Leukot Essent Fatty Acids        ISSN: 0952-3278            Impact factor:   4.006


  6 in total

1.  Neutrophil activation, protein oxidation and ceruloplasmin levels in children with Henoch-Schönlein purpura.

Authors:  Aydin Ece; Selvi Kelekçi; Aşkin Hekimoğlu; Halil Kocamaz; Hasan Balik; Ilyas Yolbaş; Ozcan Erel
Journal:  Pediatr Nephrol       Date:  2007-04-03       Impact factor: 3.714

2.  Elevated plasma advanced oxidation protein products in children with Henoch-Schonlein purpura.

Authors:  Nurcan Keskin; Mahmut Civilibal; Murat Elevli; Macit Koldas; Nilgun Selcuk Duru; Humeyra Ozturk
Journal:  Pediatr Nephrol       Date:  2011-05-08       Impact factor: 3.714

3.  Elevated serum heme oxygenase-1 and insulin-like growth factor-1 levels in patients with Henoch-Schonlein purpura.

Authors:  Tao Chen; Zai-Pei Guo; Yu-Hong Zhang; Ying Gao; Hong-Jie Liu; Jing-Yi Li
Journal:  Rheumatol Int       Date:  2009-12-16       Impact factor: 2.631

4.  Antioxidant enzyme activities, lipid peroxidation, and total antioxidant status in children with Henoch-Schönlein purpura.

Authors:  Aydin Ece; Selvi Kelekçi; Halil Kocamaz; Aşkin Hekimoğlu; Hasan Balik; Ilyas Yolbaş; Ozcan Erel
Journal:  Clin Rheumatol       Date:  2007-07-24       Impact factor: 2.980

5.  Evaluation of oxidative stress and erythrocyte properties in children with henoch-shoenlein purpura.

Authors:  Dolunay Gurses; Nusret Parlaz; Melek Bor-Kucukatay; Vural Kucukatay; Gulten Erken
Journal:  Iran J Pediatr       Date:  2014-04       Impact factor: 0.364

Review 6.  A Review of the Mechanism of Vascular Endothelial Injury in Immunoglobulin A Vasculitis.

Authors:  Shanshan Xu; Shanshan Han; Yanlin Dai; Long Wang; Xia Zhang; Ying Ding
Journal:  Front Physiol       Date:  2022-03-16       Impact factor: 4.566

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.